Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75 Mg,

May 10, 2019 at 1:30 pm PDT

ScieGen Pharmaceuticals, Inc. is voluntarily recalling listed lots, within expiry, of Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg dosage forms to the consumer level. These products are being recalled due to the presence of an impurity.

KIRO

Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75 Mg,

Most Read

Driver stopped with fake registration tab in Bellingham

Bao the otter pup will make his debut at Point Defiance Zoo

Copper wire thieves disrupt Sound Transit 1 Line, no reopening time set

SR 99 lane closures could last into March

Ghislaine Maxwell fights release of more Epstein documents, calling disclosure law unconstitutional